Ferritin and myalgic encephalomyelitis/chronic fatigue syndrome in post COVID-19, an unexpected facet of the hyperferritinemic syndrome?

J Psychosom Res. 2023 Jun:169:111231. doi: 10.1016/j.jpsychores.2023.111231. Epub 2023 Mar 15.

¹ Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, delta 6 building, PO Box 67100, L'Aquila, Italy. Electronic address: piero.ruscitti@univaq.it.
² Medicine & Rheumatology Unit, IRCCS Istituto Ortopedico Rizzoli (IOR), 40136 Bologna, Italy; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40125 Bologna, Italy.
³ Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel HaShomer 5265601, Israel; Sackler Faculty of Medicine, Ariel University, Ariel 40700, Israel; Laboratory of the Mosaic of Autoimmunity, Saint-Petersburg State University, 199034 St. Petersburg, Russia.

No abstract available

Keywords: COVID-19; Ferritin; Myalgic encephalomyelitis/chronic fatigue syndrome; Post-COVID-19 syndrome.

Publication types